Skip to search formSkip to main contentSkip to account menu

Moclobemide

Known as: Moclobamide, 4-Chlor-N-(2-morpholinoethyl)benzamid, Moclobemida 
A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
National Institutes of Health

Related topics

Related topics

21 relations

Broader (2)

Antidepressive AgentsMonoamine Oxidase Inhibitors

Narrower (11)

ArimaAurorixChem mart MoclobemideDBL Moclobemide
In BloodMoclobemide:MCnc:Pt:Ser/Plas:QnMoclobemide:SCnc:Pt:Ser/Plas:Qnagonists

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
The significance of different health institutions and their respective contributions of active pharmaceutical ingredients to wastewater.
Highly Cited
2006
Highly Cited
2006
Moclobemide upregulated Bcl‐2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular‐regulated kinase pathway
1 Moclobemide (MB) is an antidepressant drug that selectively and reversibly inhibits monoamine oxidase‐A. Recent studies have… 
Highly Cited
2002
Highly Cited
2002
Omeprazole hydroxylation is inhibited by a single dose of moclobemide in homozygotic EM genotype for CYP2C19.
AIMS The pharmacokinetics of omeprazole and its metabolites in healthy subjects were evaluated to determine if a single dose of… 
Highly Cited
1997
Highly Cited
1997
An open trial of moclobemide in the treatment of post‐traumatic stress disorder
Traditional monoamine oxidase inhibitors have shown efficacy in the treatment of post-traumatic stress disorder, but their use is… 
Review
1997
Review
1997
Delayed onset of action of antidepressant drugs? Survey of recent results
1996
1996
Additive effects of glyburide and antidepressants in the forced swimming test: Evidence for the involvement of potassium channel blockade
Highly Cited
1993
Highly Cited
1993
The sleep eeg and nocturnal hormonal secretion studies on changes during the course of depression and on effects of cns-active drugs
Highly Cited
1990
Highly Cited
1990
Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase‐A, compared with other antidepressants and placebo
Moclobemide, a new selective and reversible inhibitor of monoamine oxidase A (RIMA), has been compared with various tricyclic… 
Highly Cited
1989
Highly Cited
1989
A Double-blind Comparative Trial of Moclobemide v. Imipramine and Placebo in Major Depressive Episodes
Patients (n = 490) suffering from a major depressive episode according to DSM-III criteria were randomly allocated to groups… 
Highly Cited
1984
Highly Cited
1984
Moclobemide and clomipramine in the treatment of depression
ABSTRACT– Moclobemide (Ro 11‐1163), a benzamide derivative, is a MAO‐inhibitor which selectively and reversibly inhibits… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)